Literature DB >> 26342698

Efficacy of combined adjuvant transarterial chemoembolization and antiviral therapy in patients with HBV-related hepatocellular carcinoma after surgery.

Song-Lin Ma1, Yang Lv1, Jing-Hang Jiang2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26342698     DOI： 10.1007/s13277-015-4026-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  13 in total

1.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Authors:  Chien-Jen Chen; Hwai-I Yang; Jun Su; Chin-Lan Jen; San-Lin You; Sheng-Nan Lu; Guan-Tarn Huang; Uchenna H Iloeje
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

Review 2.  Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy?

Authors:  Liang-He Yu; Nan Li; Jie Shi; Wei-Xing Guo; Meng-Chao Wu; Shu-Qun Cheng
Journal:  Ann Surg Oncol       Date:  2014-03       Impact factor: 5.344

3.  Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study.

Authors:  Jianhua Yin; Nan Li; Yifang Han; Jie Xue; Yang Deng; Jie Shi; Weixing Guo; Hongwei Zhang; Hongyang Wang; Shuqun Cheng; Guangwen Cao
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

4.  Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.

Authors:  Chun-Ying Wu; Yi-Ju Chen; Hsiu J Ho; Yao-Chun Hsu; Ken N Kuo; Ming-Shiang Wu; Jaw-Town Lin
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

5.  Comparative efficacy of postoperative transarterial chemoembolization with or without antiviral therapy for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Shao-Liang Zhu; Jian-Hong Zhong; Yang Ke; Hui-Min Xiao; Liang Ma; Jie Chen; Xue-Mei You; Le-Qun Li
Journal:  Tumour Biol       Date:  2015-03-21

6.  Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Albert C Y Chan; Kenneth S H Chok; Wai Key Yuen; See Ching Chan; Ronnie T P Poon; Chung Mau Lo; Sheung Tat Fan
Journal:  Arch Surg       Date:  2011-06

7.  Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection.

Authors:  Xiaohong Chen; Boheng Zhang; Xin Yin; Zhenggang Ren; Shuangjian Qiu; Jian Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-03       Impact factor: 4.553

8.  Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial.

Authors:  Gang Huang; Wan Yee Lau; Zhen-Guang Wang; Ze-Ya Pan; Sheng-Xian Yuan; Feng Shen; Wei-Ping Zhou; Meng-Chao Wu
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969

9.  Nucleos(t)ide analogue therapy for HBV-related HCC after hepatic resection: clinical benefits and unanswered questions.

Authors:  Jian-Hong Zhong
Journal:  Tumour Biol       Date:  2014-11-28

10.  Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy.

Authors:  Yang Ke; Liang Ma; Xue-Mei You; Sheng-Xin Huang; Yong-Rong Liang; Bang-De Xiang; Le-Qun Li; Jian-Hong Zhong
Journal:  Cancer Biol Med       Date:  2013-09       Impact factor: 4.248
View more
  1 in total

1.  Feasibility of combining adjuvant transarterial chemoembolization with nucleos(t)ide analog therapy for patients with HBV-associated hepatocellular carcinoma after hepatectomy.

Authors:  Wen-Feng Gong; Jian-Hong Zhong; Bang-DE Xiang; LE-Qun Li
Journal:  Mol Clin Oncol       Date:  2016-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.